Seattle-based Amnis has been issued eight U.S. patents over the last year and a half covering the “architecture, subsystems, algorithms, cell-probing techniques, and applications” of its ImageStream high-speed flow imaging system for cellular analysis, the company said on May 26.

Since the patents have been in the public domain for quite some time, the bigger news may have been that the company has also filed six new patents covering specific drug discovery, basic research, and diagnostic applications that can be performed using the instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.